VCM
CRL icon

Voleon Capital Management’s Charles River Laboratories CRL Stock Holding History

Voleon Capital Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-28,000
Closed -$4.28M – 38
2019
Q4 		$4.28M Buy
28,000
+16,000
+133% +$2.22M 0.25% 71
2019
Q3 		$1.59M Buy
+12,000
New +$1.61M 0.12% 108
2019
Q1 		– Sell
-16,000
Closed -$1.81M – 32
2018
Q4 		$1.81M Buy
+16,000
New +$2M 0.17% 53

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Voleon Capital Management's CRL Position: Q1 2020 in Review

Voleon Capital Management sold out of Charles River Laboratories (CRL) in Q1 2020, closing a stake of 28,000 shares — an estimated $4.28M sold.

Voleon Capital Management first reported a position in CRL in Q4 2018 and held it in 3 quarters. The position peaked at $4.28M in Q4 2019. 414 funds tracked by Wall St. Rank hold CRL as of Q1 2020.

  • Voleon Capital Management reported no remaining Charles River Laboratories position as of Q1 2020 after selling out during the quarter.
  • Voleon Capital Management sold 28,000 Charles River Laboratories shares in Q1 2020, an estimated $4.28M.
  • Voleon Capital Management first reported a position in Charles River Laboratories in Q4 2018 and held it in 3 quarters.
  • Voleon Capital Management's Charles River Laboratories position peaked at $4.28M in Q4 2019.
  • 414 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2020.

Based on Voleon Capital Management's 13F filing for Q1 2020.